6
Jul 2026
A Scottish microsimulation study found that reducing meat and dairy intake, especially red meat among high consumers, could improve modeled health and environmental outcomes without increasing diet costs. However, some nutrient intakes, particularly calcium and iodine, declined, highlighting the need for carefully planned substitutions and fortified alternatives.
6
Jul 2026
The U.S. Food and Drug Administration (FDA) has approved a new therapy regimen for patients with "double-positive" metastatic breast cancer based on results of the phase 3 PATINA study led by Otto Metzger, MD, Associate Medical Director of International Strategic Initiatives at Dana-Farber Cancer Institute.
6
Jul 2026
Tuberculosis, caused by the bacterium Mycobacterium tuberculosis (Mtb) is the world's deadliest single-agent caused infection, responsible for 1.23 million deaths in 2024, according to the World Health Organization.
6
Jul 2026
In people with severely compromised immune systems, the JC polyomavirus can trigger a currently untreatable, usually fatal brain disease.
6
Jul 2026
A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists, and IAVI has the potential to protect humans from developing HIV infection and AIDS.
6
Jul 2026
Parkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than ten million people worldwide. While current therapies address disease symptoms, they do not prevent the underlying neurodegeneration that drives the disease.
6
Jul 2026
A new study generated one of the most comprehensive spatially resolved transcriptomic maps of cellular communication between bone and skeletal muscle in a young mouse.
6
Jul 2026
In health care, it is often the smallest moments that carry the greatest meaning - a quiet conversation with a patient, a shared reflection with colleagues, or a hand held in silence.
6
Jul 2026
A new case report was published in Volume 17 of Oncotarget on July 2, 2026, titled "Renal oncocytoma: Α case report and literature review."
6
Jul 2026
The researchers treated 5‑month‑old 5xFAD mice – a model with aggressive amyloid deposition – with 810‑nm light (25 mW/cm² at the scalp, ~6.25 mW/cm² brain dose for CW, and half that for 40‑Hz due to 50% duty cycle) for 10 minutes daily over 37 days.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
